AstraZeneca and Lucy Cavendish College establish women in science and leadership mentoring collaboration

The initiative forms part of the AstraZeneca Exchange programme supporting innovation and collaboration amongst diverse stakeholders in life sciences clusters around the company’s three global strategic R&D hubs

 

AstraZeneca and Lucy Cavendish College, University of Cambridge, today announced that they have established a strategic collaboration to support their common goals of advancing women in science and business leadership, building on their existing relationship since the Company relocated its global HQ and R&D centre to Cambridge in 2016.

The collaboration is the latest partnership in AstraZeneca’s programme of inspiring and supporting careers in STEM through volunteering out-reach initiatives and mentoring across the Cambridge community.

As part of the collaboration, AstraZeneca employees will mentor Lucy Cavendish College students, supporting their scientific projects as well as career and personal development. The mentors will provide advice and insights on career and work placement opportunities in the life sciences sector generally and in the biopharmaceutical industry specifically, including at AstraZeneca’s global hub in Cambridge. A successful ‘speed mentoring’ pilot event has already taken place and a series of group as well as individual mentoring programmes are being planned. A lecture programme promoting Women in Science and Leadership will also be held during the year.

AstraZeneca and MedImmune currently have a pool of around 70 employees from a wide variety of specialisms and disciplines who are volunteering as mentors to share their expertise and experience with partner organisations across the vibrant Cambridge life sciences eco-system.

Commenting on the collaboration, Shaun Grady, Vice President of Global Business Development, said: “Mentoring is not only a fantastic way to support talented individuals who benefit from the shared expertise and experience, but it is also a great way for mentors to ‘give back’ while developing their leadership skills. We’re pleased to have mentored numerous entrepreneurs emerging from the Judge Business School Accelerate and Pitch@Palace programmes, and we recently announced a partnership supporting start-up companies at the Babraham Research Campus incubator. Our new collaboration with Lucy Cavendish College is a natural extension of our partnership network and offers a great model for how we might work with other colleges in Cambridge. It’s very exciting to be working with such a high calibre group of inspirational women studying in what is a uniquely supportive environment”.

Jackie Ashley, President, Lucy Cavendish College, said: “Relatively few women embark on careers in science, and we want to ensure that there are as few barriers as possible for women who have the potential to be successful in this field. Our partnership with AstraZeneca aims to tackle this issue head on, with exciting initiatives for our enthusiastic students, including mentoring, careers advice and personal development for those interested in having a scientific career. We look forward to working with AstraZeneca on this exciting new venture.”

NOTES TO EDITORS

About Lucy Cavendish College

Lucy Cavendish is the only women's college in Europe exclusively for students aged 21 or over, and a unique part of the University of Cambridge. The student body is 1/3 undergraduate and 2/3 graduate, the students themselves come from over sixty countries, and a wide variety of educational and professional backgrounds. Many have changed careers or overcome significant challenges in order to reach University. At the undergraduate level, the College is particularly strong in Medicine, Law, Veterinary Medicine, Psychology, the Social Sciences and English. Our graduate community is well represented in Engineering Medical Sciences and Social Sciences. For more information, please visit http://www.lucy-cav.cam.ac.uk and follow us on Twitter @LucyCavColl

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology; Cardiovascular; Renal & Metabolism, and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.
 


CONTACTS

Media Relations

 

 

 

 

AstraZeneca

   

Charlotte Fitzgerald

Cambridge media

+44 782 435 0456

Rob Skelding

UK/Global media

+44 203 749 5821

Matt Kent

UK/Global media

+44 203 749 5906